Chemoinformaics analysis of 1,7-DI-EPI-ALPHA-CEDRENE
| Molecular Weight | 204.357 | nRot | 0 |
| Heavy Atom Molecular Weight | 180.165 | nRig | 13 |
| Exact Molecular Weight | 204.188 | nRing | 3 |
| Solubility: LogS | -5.585 | nHRing | 0 |
| Solubility: LogP | 5.161 | No. of Aliphatic Rings | 3 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 3 |
| Atoms Count | 39 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 15 | No. of Aromatic Carbocycles | 0 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 2 | No. Saturated Carbocycles | 2 |
| No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 0 | APOL | 41.053 |
| nHD | 0 | BPOL | 24.077 |
| QED | 0.513 |
| Synth | 5.533 |
| Natural Product Likeliness | 3.518 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.008 |
| Pgp-sub | 0 |
| HIA | 0.005 |
| CACO-2 | -4.514 |
| MDCK | 0.0000151 |
| BBB | 0.828 |
| PPB | 0.961457 |
| VDSS | 2.038 |
| FU | 0.0419343 |
| CYP1A2-inh | 0.244 |
| CYP1A2-sub | 0.373 |
| CYP2c19-inh | 0.271 |
| CYP2c19-sub | 0.921 |
| CYP2c9-inh | 0.481 |
| CYP2c9-sub | 0.618 |
| CYP2d6-inh | 0.049 |
| CYP2d6-sub | 0.811 |
| CYP3a4-inh | 0.297 |
| CYP3a4-sub | 0.288 |
| CL | 15.754 |
| T12 | 0.049 |
| hERG | 0.006 |
| Ames | 0.004 |
| ROA | 0.089 |
| SkinSen | 0.047 |
| Carcinogencity | 0.031 |
| EI | 0.921 |
| Respiratory | 0.771 |
| NR-Aromatase | 0.012 |
| Antiviral | Yes |
| Prediction | 0.932264 |